Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 243 Jul 27 – Oct 24, 2026
- Disclosed funding
- $6.3B 177 disclosed amounts
- Median round
- $14.2M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| AB Aptatek Biosciences, Inc.Company profile Aptatek Biosciences develops connected diagnostic tools for metabolic monitoring at home. Its investigational PheCheck programme measures blood phenylalanine for people with PKU. Aptatek Biosciences develops connected diagnostic tools for metabolic monitoring at home. Its investigational PheCheck programme measures blood phenylalanine for people with PKU. | Undisclosed | Initial close of financingUndisclosed | Healthtech, Biotech | United States | Investors | |
| O OrtetCompany profile Ortet is an AI research lab building models and shared computing and data infrastructure for healthcare and life-science work. Ortet is an AI research lab building models and shared computing and data infrastructure for healthcare and life-science work. | $500M | Investment commitmentUndisclosed | Healthtech, AI | United States | Investors | |
| AP Astrocyte Pharmaceuticals Inc.Company profile Astrocyte Pharmaceuticals develops treatments intended to protect brain tissue after concussion, traumatic brain injury and stroke by targeting astrocytes. Astrocyte Pharmaceuticals develops treatments intended to protect brain tissue after concussion, traumatic brain injury and stroke by targeting astrocytes. | $9.5M | Series B | Healthtech, Biotech | United States | Investors | |
| V VytalyouCompany profile Vytalyou provides doctor-led preventive-health services combining diagnostics, personalised interventions and medically supervised care. Vytalyou provides doctor-led preventive-health services combining diagnostics, personalised interventions and medically supervised care. | ₹90M | Pre-Series ASeed | Healthtech | India | Investors | |
 AnaCardioCompany profile AnaCardio develops oral medicines intended to improve heart muscle contraction in people with heart failure. AnaCardio develops oral medicines intended to improve heart muscle contraction in people with heart failure. | €62.5M | Series B | Healthtech, Biotech | Sweden | Investors | |
| AT Aptadir TherapeuticsCompany profile RNA therapeutics designed to restore expression of silenced genes RNA therapeutics designed to restore expression of silenced genes | €40M | Seed | Healthtech, Biotech | Italy | Investors | |
| TH Tiny HealthCompany profile Tiny Health provides gut and vaginal microbiome testing and analysis to help families understand microbiome health across life stages. Tiny Health provides gut and vaginal microbiome testing and analysis to help families understand microbiome health across life stages. | $33M | Series B | Healthtech | — | Investors | |
| a ai3BioCompany profile ai3Bio develops therapies designed to remove disease-causing Th17 immune cells, using antibody and lipid-nanoparticle platforms to address autoimmune disease. ai3Bio develops therapies designed to remove disease-causing Th17 immune cells, using antibody and lipid-nanoparticle platforms to address autoimmune disease. | $48M | Series A | Healthtech, Biotech | United States | Investors | |
| E EliseAICompany profile Agentic AI software for housing operators and healthcare providers that automates customer conversations and operational workflows. Agentic AI software for housing operators and healthcare providers that automates customer conversations and operational workflows. | $350M | Growth financingUndisclosed | Healthtech, AI | United States | Investors | |
| M MoneyStackCompany profile MoneyStack provides financial counselling within behavioural-health programmes, helping people address money problems alongside treatment. MoneyStack provides financial counselling within behavioural-health programmes, helping people address money problems alongside treatment. | $1M | Undisclosed | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 27, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
6rounds1led - 2Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
6rounds2led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
5rounds0led - 4Y Combinator (YC)
Vitalize, Angle Health, Metriport
5rounds0led - 5European Investment Bank
HighLife, MMI, Tensive
5rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.